U.S. Department Of Defense

Type

Government organization

Status

Active

Location

Washington, United States

Total investments

189

Average round size

18M

Portfolio companies

171

Rounds per year

2.45

Lead investments

72

Follow on index

0.09

Exits

54

Areas of investment
BiotechnologyInformation TechnologyHealth CareEducationManufacturingMedical DeviceMedicalLife SciencePharmaceuticalTherapeutics

Summary

U.S. Department of Defense is the famous Corporate Investor, which was founded in 1947. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Washington.

The fund was created by Reina Staley.

Speaking about the real fund results, this Corporate Investor is 60 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from U.S. Department of Defense is 5-10 millions dollars. The high activity for fund was in 2018. Deals in the range of 5 - 10 millions dollars are the general things for fund. The increased amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. This U.S. Department of Defense works on 6 percentage points less the average amount of lead investments comparing to the other organizations.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the U.S. Department of Defense, startups are often financed by National Institutes of Health, RMI Partners, Innovacorp. The meaningful sponsors for the fund in investment in the same round are US Department of Energy, National Institutes of Health, Congressionally Directed Medical Research Programs. In the next rounds fund is usually obtained by National Institutes of Health, Taiwania Capital, National Heart, Lung and Blood Institute.

Among the most popular fund investment industries, there are Medical Device, Pharmaceutical. Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Sikorsky Aircraft, Pixelligent, SPR Therapeutics.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
189
Lead investments
72
Exits
54
Rounds per year
2.45
Follow on index
0.09
Investments by industry
  • Biotechnology (86)
  • Health Care (61)
  • Medical (49)
  • Manufacturing (26)
  • Pharmaceutical (24)
  • Show 142 more
Investments by region
  • United States (163)
  • Canada (10)
  • South Korea (1)
  • Luxembourg (1)
  • Germany (1)
  • Show 7 more
Peak activity year
2023
Number of Unicorns
5
Number of Decacorns
6
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
32
Avg. valuation at time of investment
332M
Group Appearance index
0.17
Avg. company exit year
17
Avg. multiplicator
5.01
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CausalTwin 21 Oct 2022 Seed 37K
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.